Baus, Christoph A.

Christoph A. Baus

Partner

christoph.baus@lw.com
christoph.baus@lw.com
    Baus, Christoph A.

    Christoph A. Baus

    Partner

    christoph.baus@lw.com

    German Litigator of the Year

    Benchmark Litigation Europe 2025

    "Unbelievably calm, thinks with strategic goals in mind and understands high-complexity matters very quickly."

    Chambers Germany 2025

    "In a high-pressure, important moment, Christoph Baus is the person I would call."

    Chambers Germany 2025

    "He has a good grasp of complex matters."

    Chambers Europe 2024

    "Offers clients strong support in large litigation matters, including on mass claims. He also shows promise in arbitration matters."

    Chambers Europe 2024

    "One of the best litigation lawyers I know. Confident, analytically brilliant and with unique experience in organizing mass proceedings."

    Legal 500 EMEA 2023

    "An outstanding litigator. Legally enormously astute, rhetorically winning and with great organizational and management skills for complex large-scale and mass proceedings."

    Legal 500 EMEA 2022

    "We feel well taken care of by Christoph Baus."

    Chambers Europe 2023

    Leading Individual – Commercial Litigation

    Legal 500 EMEA 2023

    Recommended – Commercial Litigation

    Who's Who Legal 2023

    Profile

    Dr. Christoph Baus, a complex commercial trial lawyer, is the current Global Vice Chair of the Complex Commercial Litigation Practice and former Global Vice Chair of the firm’s Litigation & Trial Department.

    Christoph represents clients at trial and in arbitration in a range of disputes, related to: 

    • Complex commercial 
    • Securities
    • Professional liability 
    • Shareholders 
    • M&A  
    • Insolvency  
    • Antitrust damages and abuse of dominance 

    Christoph has unparalleled experience in courtrooms and has led some of the most complex and high-profile cases, including Germany’s largest mass securities litigation matter. He is regularly lauded by leading legal publications, including JUVE, Legal 500, and Chambers Europe, and has been compared to Cicero and James Bond.

    Experience

    Christoph’s representative experience includes advising: 

    Mass Actions and Securities Litigation

    • DAX 30 company in German and US securities litigation
    • Scottish Widows Limited in connection with the alleged misselling of insurance policies 
    • Scholz Holding AG in securities litigation
    • Leading international financial institution in thousands of customer claims

    M&A Litigation/Arbitration

    • Rhön Klinikum AG to secure €3.07 billion sale of healthcare institutions to Helios, subsidiary of Fresenius Medical Care
    • European private equity house in post-M&A ICC arbitration
    • UK public company in post-M&A arbitration
    • Hamburg new economy company in post-M&A DIS arbitration with US corporation

    Commercial and Antitrust Disputes

    • DAX 30 company in cartel damages cases from various world-wide cartels
    • Main shareholder in European pharma enterprise in shareholder arbitration
    • Main shareholder in German partnership (ship management) in €2 billion shareholder arbitration
    • Leading consumer company in a series of competition-related claims against a competitor 
    • International cable company in abuse of dominance case

    Qualifications

    Bar Qualification

    • Rechtsanwalt (Germany)

    Education

    • Second German State Exam, Higher Regional Court, Braunschweig
    • Dr. jur., University of Goettingen
    • First German State Exam, University of Goettingen

    Languages Spoken

    • English
    • German

    Practices

    Industries

    Recognition

    News & Insights

    Up angle of European Union flags at Berlaymont Building, headquarters of the European Commission in Brussels, Belgium.
    August 14, 2026 Podcast

    Europe Litigation: Mass Actions at a Global Scale

    Latham lawyers discuss how the EU Representative Actions Directive impacts mass actions, as well as how clients can navigate potential challenges arising from the directive.
    Read More